These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 33074046)
1. Response of breast cancer carcinoma spheroids to combination therapy with radiation and DNA-PK inhibitor: growth arrest without a change in Yu J; Lu R; Nedrow JR; Sgouros G Int J Radiat Biol; 2020 Dec; 96(12):1534-1540. PubMed ID: 33074046 [TBL] [Abstract][Full Text] [Related]
2. Radio-sensitization of human leukaemic MOLT-4 cells by DNA-dependent protein kinase inhibitor, NU7441. Tichy A; Durisova K; Salovska B; Pejchal J; Zarybnicka L; Vavrova J; Dye NA; Sinkorova Z Radiat Environ Biophys; 2014 Mar; 53(1):83-92. PubMed ID: 24100951 [TBL] [Abstract][Full Text] [Related]
3. DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin. Ciszewski WM; Tavecchio M; Dastych J; Curtin NJ Breast Cancer Res Treat; 2014 Jan; 143(1):47-55. PubMed ID: 24292814 [TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441. Zhao Y; Thomas HD; Batey MA; Cowell IG; Richardson CJ; Griffin RJ; Calvert AH; Newell DR; Smith GC; Curtin NJ Cancer Res; 2006 May; 66(10):5354-62. PubMed ID: 16707462 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the Radiosensitizing Effect of ATR, ATM and DNA-PK Kinase Inhibitors on Cervical Carcinoma Cells. Vávrová J; Zárybnická L; Jošt P; Tichý A; Řezáčová M; Šinkorová Z; Pejchal J Folia Biol (Praha); 2016; 62(4):167-74. PubMed ID: 27643582 [TBL] [Abstract][Full Text] [Related]
6. Nontoxic concentration of DNA-PK inhibitor NU7441 radio-sensitizes lung tumor cells with little effect on double strand break repair. Sunada S; Kanai H; Lee Y; Yasuda T; Hirakawa H; Liu C; Fujimori A; Uesaka M; Okayasu R Cancer Sci; 2016 Sep; 107(9):1250-5. PubMed ID: 27341700 [TBL] [Abstract][Full Text] [Related]
7. Inactivation of DNA-PK by knockdown DNA-PKcs or NU7441 impairs non-homologous end-joining of radiation-induced double strand break repair. Dong J; Ren Y; Zhang T; Wang Z; Ling CC; Li GC; He F; Wang C; Wen B Oncol Rep; 2018 Mar; 39(3):912-920. PubMed ID: 29344644 [TBL] [Abstract][Full Text] [Related]
8. Effect of resveratrol on the radiosensitivity of 5-FU in human breast cancer MCF-7 cells. Aghamiri S; Jafarpour A; Zandsalimi F; Aghemiri M; Shoja M J Cell Biochem; 2019 Sep; 120(9):15671-15677. PubMed ID: 31069826 [TBL] [Abstract][Full Text] [Related]
9. Identification of dual DNA-PK MDR1 inhibitors for the potentiation of cytotoxic drug activity. Mould E; Berry P; Jamieson D; Hill C; Cano C; Tan N; Elliott S; Durkacz B; Newell D; Willmore E Biochem Pharmacol; 2014 Mar; 88(1):58-65. PubMed ID: 24418411 [TBL] [Abstract][Full Text] [Related]
10. Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination. Tavecchio M; Munck JM; Cano C; Newell DR; Curtin NJ Cancer Chemother Pharmacol; 2012 Jan; 69(1):155-64. PubMed ID: 21630086 [TBL] [Abstract][Full Text] [Related]
11. Lithium increases radiosensitivity by abrogating DNA repair in breast cancer spheroid culture. Rouhani M; Goliaei B; Khodagholi F; Nikoofar A Arch Iran Med; 2014 May; 17(5):352-60. PubMed ID: 24784865 [TBL] [Abstract][Full Text] [Related]
12. 3D tumour spheroids for the prediction of the effects of radiation and hyperthermia treatments. Brüningk SC; Rivens I; Box C; Oelfke U; Ter Haar G Sci Rep; 2020 Feb; 10(1):1653. PubMed ID: 32015396 [TBL] [Abstract][Full Text] [Related]
13. Radiosensitivity, repair capacity, and stem cell fraction in human soft tissue tumors: an in vitro study using multicellular spheroids and the colony assay. Stuschke M; Budach V; Klaes W; Sack H Int J Radiat Oncol Biol Phys; 1992; 23(1):69-80. PubMed ID: 1572832 [TBL] [Abstract][Full Text] [Related]
14. Radioresponsiveness of human glioma, sarcoma, and breast cancer spheroids depends on tumor differentiation. Stuschke M; Budach V; Sack H Int J Radiat Oncol Biol Phys; 1993 Oct; 27(3):627-36. PubMed ID: 8226158 [TBL] [Abstract][Full Text] [Related]
15. Changes in the response of MCF-7 cells to ionizing radiation after the combination of ATM and DNA-PK inhibition. Ćmielová J; Havelek R; Vávrová J; Řezáčová M Med Oncol; 2015 May; 32(5):138. PubMed ID: 25801233 [TBL] [Abstract][Full Text] [Related]
16. Multimodality therapy: radiation and continuous concomitant cis-platinum and PKC inhibition in a cervical carcinoma model. Sommers GM; Alfieri AA Cancer Invest; 1998; 16(7):462-70. PubMed ID: 9774953 [TBL] [Abstract][Full Text] [Related]
17. Testing chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids. Halfter K; Hoffmann O; Ditsch N; Ahne M; Arnold F; Paepke S; Grab D; Bauerfeind I; Mayer B J Transl Med; 2016 May; 14(1):112. PubMed ID: 27142386 [TBL] [Abstract][Full Text] [Related]
18. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. Phillips TM; McBride WH; Pajonk F J Natl Cancer Inst; 2006 Dec; 98(24):1777-85. PubMed ID: 17179479 [TBL] [Abstract][Full Text] [Related]
19. Alpha-particle emitting atomic generator (Actinium-225)-labeled trastuzumab (herceptin) targeting of breast cancer spheroids: efficacy versus HER2/neu expression. Ballangrud AM; Yang WH; Palm S; Enmon R; Borchardt PE; Pellegrini VA; McDevitt MR; Scheinberg DA; Sgouros G Clin Cancer Res; 2004 Jul; 10(13):4489-97. PubMed ID: 15240541 [TBL] [Abstract][Full Text] [Related]
20. Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemia. Elliott SL; Crawford C; Mulligan E; Summerfield G; Newton P; Wallis J; Mainou-Fowler T; Evans P; Bedwell C; Durkacz BW; Willmore E Br J Haematol; 2011 Jan; 152(1):61-71. PubMed ID: 21083655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]